These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18069195)

  • 1. [New effective dosage of valsartan. High dosage--effective against high blood pressure].
    MMW Fortschr Med; 2007 Nov; 149(46):52-3. PubMed ID: 18069195
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin receptor blockers and myocardial infarction: the importance of dosage.
    Sarzani R; Dessì-Fulgheri P
    J Hypertens; 2006 Aug; 24(8):1679-81; author reply 1681-2. PubMed ID: 16877973
    [No Abstract]   [Full Text] [Related]  

  • 3. Valsartan. Just a second-line antihypertensive drug.
    Can Fam Physician; 1999 Nov; 45():2626-8, 2630-3. PubMed ID: 10587770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [First fixed combination of sartan and high-dosage diuretic. A strong duo against high blood pressure].
    MMW Fortschr Med; 2004 Apr; 146(14):45. PubMed ID: 15344757
    [No Abstract]   [Full Text] [Related]  

  • 5. [Valsartan: arguments for the high dose concept].
    MMW Fortschr Med; 2006 Dec; 148(51-52):54-5. PubMed ID: 17619348
    [No Abstract]   [Full Text] [Related]  

  • 6. [Valsartan improves symptoms and quality of life in patients with chronic heart failure].
    Baumhäkel M; Müller U; Böhm M
    MMW Fortschr Med; 2008 Apr; 150 Suppl 1():48-53. PubMed ID: 18540333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47. PubMed ID: 19528888
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dilemma of antihypertensive therapy: high blood pressure diminishes, potency sometimes, too].
    MMW Fortschr Med; 2006 Sep; 148(38):17. PubMed ID: 17036956
    [No Abstract]   [Full Text] [Related]  

  • 9. [Scientific evidence--applied in routine general practice. Successful decrease in pressure and risk].
    MMW Fortschr Med; 2006 May; 148(18):42-3. PubMed ID: 16736689
    [No Abstract]   [Full Text] [Related]  

  • 10. Is the reno-protective effect of valsartan dose dependent? A comparative study of 80 and 160 mg day(-1).
    Saikawa T; Sasaki J; Biro S; Kono S; Otonari T; Ikeda Y;
    Hypertens Res; 2010 Sep; 33(9):886-91. PubMed ID: 20555331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination.
    Vivencio B
    Curr Med Res Opin; 2009 Sep; 25(9):2267-8; author reply 2268-9. PubMed ID: 19630488
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin receptor blockers: dose does matter.
    Sarzani R; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 Mar; 26(3):607-8; author reply 608. PubMed ID: 18300874
    [No Abstract]   [Full Text] [Related]  

  • 13. [The value of VALUE--a hypertension study which compared valsartan with amlodipine. New data support early, optimal blood pressure control for high-risk patients].
    Nilsson PM
    Lakartidningen; 2004 Jul; 101(30-31):2426-7. PubMed ID: 15314941
    [No Abstract]   [Full Text] [Related]  

  • 14. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
    He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
    J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of AT1-angiotensin II receptor blocker valsartan in clinical practice].
    Maksimov ML; Mochkin IA; Starodubtsev AK
    Kardiologiia; 2011; 51(8):77-84. PubMed ID: 21942964
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.
    Krum H; Carson P; Farsang C; Maggioni AP; Glazer RD; Aknay N; Chiang YT; Cohn JN
    Eur J Heart Fail; 2004 Dec; 6(7):937-45. PubMed ID: 15556056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.
    Brachmann J; Ansari A; Mahla G; Handrock R; Klebs S
    Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A drug safety evaluation of valsartan.
    Fogari R; Zoppi A
    Expert Opin Drug Saf; 2011 Mar; 10(2):295-303. PubMed ID: 21142805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.
    Schmieder RE; Kjeldsen SE; Julius S; McInnes GT; Zanchetti A; Hua TA;
    J Hypertens; 2008 Mar; 26(3):403-11. PubMed ID: 18300848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.